Diabetes and the risk of delayed union or non-union of fractures: evidence from a systematic review and meta-analysis Authors: Jun Li, Zixin Cai, Yi Shen, Jingjing Zhang, Lu Wang, Tang Liu Published: 2026 ABSTRACT As the global prevalence of diabetes continues to rise, an increasing number of fracture patients present with metabolic comorbidities, raising concerns regarding their healing outcomes. This systematic review and meta-analysis aimed to provide an updated and comprehensive assessment of the association between diabetes and delayed union or non-union. A comprehensive search of PubMed, Embase, Web of Science, Scopus, CINAHL, and the Cochrane Library was performed from inception to November 2025, following PRISMA guidelines. Two reviewers independently performed study selection, data extraction, and quality assessment. Odds ratios (ORs) with 95% confidence intervals (CIs) were pooled using random-effects models. Heterogeneity was quantified using the I2 statistic, and subgroup and sensitivity analyses were conducted to explore potential effect modifiers. Study quality was evaluated using the Newcastle–Ottawa Scale (NOS), and publication bias was assessed using funnel plots, Begg’s test, and Egger’s test. Overall, diabetes was associated with an increased risk of delayed union or non-union (OR = 1.61, 95% CI 1.44–1.81; I2 = 76.6%). Sensitivity analysis restricted to high-quality studies (n = 30) yielded consistent results (OR = 1.60, 95% CI 1.56–1.65), indicating robust findings. Subgroup analyses suggested that the magnitude of association varied by fracture location, diabetes type, and diabetes severity. Type 1 diabetes, complicated diabetes, and diaphyseal long-bone fractures demonstrated particularly elevated risks. No significant publication bias was detected. In conclusion, diabetes is associated with an increased risk of delayed union or non-union, and this effect appears more pronounced in certain clinical subgroups. These findings highlight the importance of considering diabetes status when assessing fracture-healing risk and emphasize the need for future prospective studies with standardized reporting of glycemic control and diabetes severity to refine risk stratification.Supplementary InformationThe online version contains supplementary material available at 10.1038/s41598-026-53682-2. Introduction Bone fractures are a common traumatic condition and represent a major public health challenge worldwide. According to the Global Burden of Disease (GBD) 2023 study, approximately 310 million new fractures occurred globally in 20231. Delayed union and non-union—which occur in an estimated 5–10% of fractures—represent particularly challenging complications, often leading to chronic pain, functional impairment, psychological burden, and substantial medical costs2–4. Multiple risk factors have been reported, including age, smoking, alcohol use, obesity, osteoporosis, and diabetes mellitus (DM)5–8. DM is a chronic metabolic disorder characterized by persistent hyperglycemia due to impaired insulin production and/or insulin resistance9,10. Accumulating evidence indicates that patients with DM have an increased risk of fractures and worse bone outcomes11. Mechanistic studies have reported multiple pathways by which diabetes impairs bone healing, including inflammation-mediated suppression of angiogenesis, oxidative stress, AGE-mediated crosslinking of collagen, and impaired function of osteoblasts and other skeletal progenitor cells12. These pathophysiological changes are increasingly relevant in aging populations and underscore the need to consider diabetes when planning fracture management. A previous meta-analysis published in 2020 evaluated the association between diabetes and fracture healing but was limited to 14 studies encompassing around 5500 patients13. Since then, the volume and diversity of clinical research on diabetes and fracture healing have grown. Therefore, a contemporary systematic review and meta-analysis that synthesizes more recent evidence is warranted to more precisely estimate the effect of diabetes on fracture-healing outcomes—such as delayed union, nonunion, reoperation, and functional recovery—and to investigate potential effect modifiers, including diabetes type, fracture location, and treatment modality. This study aims to systematically review and quantitatively synthesize decades of clinical research to clarify the relationship between diabetes and fracture healing, perform subgroup and sensitivity analyses to provide evidence-based guidance for clinicians managing fractures in patients with diabetes as well as recommendations for future research. Methods Search strategy The study was performed under the guidance of PRISMA (the preferred reporting item for systematic reviews and meta-analyses)14. A comprehensive search of PubMed, Embase, Web of Science, Scopus, CINAHL, and the Cochrane Library was performed from inception to November 2025. The search terms included: “Fracture” OR “Diabetes Mellitus” OR “non-union” OR “delayed union” OR “fracture healing”. The specific search strategy is shown in the Supplementary method. This systematic review and meta-analysis was registered with PROSPERO (CRD42024543498) on 20 May 2024. Study selection All eligible articles were imported into EndNote X9 software for management and independently reviewed by two authors (JL and ZC). Discrepancies between authors were resolved by negotiation with the help of the corresponding author (TL). Studies were included in the analysis according to the following criteria: (1) participants were diagnosed with fractures; (2) fracture healing outcomes were compared between diabetic and non-diabetic patients. The exclusion criteria were shown as follows: (1) reviews, letters, comments, replies, case reports, basic research, and animal studies; (2) no specific data comparing diabetic and non-diabetic patients, or the data are not fully available; (3) arthrodesis or osteotomy was performed; (4) number of cases: less than 30. Data extraction and quality assessment Two investigators independently extracted the following useful data from the included studies: (1) information about the included studies, including first author, publication year, country, and study design; (2) characteristics of the participants, including mean age, number of male patients, and sample size; (3) information related to fractures, including fracture location, and definition of delayed union or non-union. The Newcastle–Ottawa Scale (NOS) was adopted to evaluate the quality of the studies by two independent evaluators (JL and CZ)15. Studies with NOS scores ≥ 7 were classified as high-quality studies. Statistical analysis Odds ratios (ORs) were used to estimate the association between diabetes and fracture healing outcomes. The overall effect test was reported as ORs and 95% confidence intervals (CIs), and results were statistically significant if the 95% CI did not contain 1. Heterogeneity was assessed using the I2 value. A value of I2 greater than 50% indicated the existence of heterogeneity, and a Random-effects model with the Mantel–Haenszel method was adopted to perform meta-analysis. Otherwise, the fixed effects model was used. We used funnel plots, Egger regression methods, and Begg regression methods to visually assess the publication bias of included studies. The sensitivity analysis was conducted to assess the robustness of the results. All statistical work, including analysis and graphical descriptions, was performed using STATA (version 12.0, Stata Corp, USA). Results Study selection The study selection process is illustrated in Fig. 1. Our systematic search of six electronic databases yielded 6,207 records. After removing 2,640 duplicates, 3,415 records were excluded following title and abstract screening. Full texts of the remaining 152 articles were assessed, of which 113 were excluded for the following reasons: no comparative analysis between diabetic and non-diabetic patients (n = 100) or extractable outcome data unavailable (n = 13). Ultimately, 39 studies met the inclusion criteria and were included in the meta-analysis. Geographically, 16 studies were conducted in the USA, 7 in China, 4 in the UK, 3 in South Korea, and the remaining 9 studies originated from Switzerland, Germany, Argentina, Malaysia, Israel, Iran, Finland, India, and the Netherlands. Key study characteristics are summarized in Table S1.Fig. 1Flow diagram of selection process. Flow diagram of selection process. Overall analysis A total of 630,788 eligible patients were included in this meta-analysis, comprising 119,530 individuals with diabetes and 511,258 without diabetes. The overall pooled incidence of delayed union or non-union was 5.6%. Incidence rates were 7.3% among diabetic patients and 5.2% among non-diabetic patients. The overall meta-analysis demonstrated that diabetic patients had a significantly higher risk of delayed union or non-union compared with non-diabetic individuals (OR = 1.61, 95% CI 1.44–1.81; I2 = 76.6%; Fig. 2). To evaluate the robustness of this association, we conducted a sensitivity analysis restricted to high-quality studies (NOS ≥ 7). The pooled effect remained essentially unchanged (OR = 1.60, 95% CI 1.56–1.65; Figure S1), confirming that the observed association was not driven by lower-quality evidence.Fig. 2Forest plot of meta-analysis evaluating the association between diabetes and delayed union/non-union. Forest plot of meta-analysis evaluating the association between diabetes and delayed union/non-union. Subgroup analyses When stratified by fracture location, diabetes was associated with higher odds of delayed union or non-union for both upper- and lower-extremity fractures (upper extremity: OR = 1.87, 95% CI 1.19–2.95; lower extremity: OR = 1.79, 95% CI 1.41–2.28; Fig. 3). To further assess the differences in fracture sites, we subdivided long bone fractures into 4 types: (1) Diaphyseal fractures of long bones, lower extremity; (2) Proximal or distal fractures of long bones, lower extremity; (3) Diaphyseal fractures of long bones, upper extremity; (4) Proximal or distal fractures of long bones, upper extremity. The results showed that the OR values of type 1, type 2, and type 3 were 3.75 (95% CI 1.22–11.59), 1.50 (95% CI 1.06–2.13) and 2.48 (95% CI 1.09–5.62), respectively. The association for proximal/distal fractures of upper-extremity long bones (type 4) did not reach statistical significance (OR: 2.59, 95% CI 0.91–7.33; I2 = 70.9%) (Figure S2). This subgroup was based on a small number of studies and showed a wide confidence interval, indicating limited precision; therefore, the result should be interpreted with caution.Fig. 3Subgroup analysis based on the location of fractures. Subgroup analysis based on the location of fractures. Ten studies reported nonunion in patients with closed fractures. Subgroup analysis showed that diabetes was significantly associated with delayed union or nonunion in patients with closed fractures (OR = 2.64, 95% CI 1.28–5.44). Three studies reported nonunion in patients with open fractures. In patients with open fractures, the effect estimate was larger but not statistically significant (OR = 3.14, 95% CI 0.41–23.79) (Fig. 4). Therefore, the finding for the open-fracture subgroup should be interpreted with caution and warrants confirmation in larger studies.Fig. 4Subgroup analysis based on open fracture and closed fracture. Subgroup analysis based on open fracture and closed fracture. Subgroup analysis based on diabetes type showed that both type 1 and type 2 diabetes were associated with an increased risk of delayed union or non-union, with pooled ORs of 2.36 (95% CI 2.12–2.62) and 1.51 (95% CI 1.24–1.84), respectively (Fig. 5). Furthermore, the incidence of impaired fracture healing was significantly higher among patients with type 1 diabetes than those with type 2 diabetes ([OR: 1.48, 95% CI 1.33–1.66; I2 = 0%]; Figure S3). We also conducted an additional subgroup analysis examining diabetes severity. Patients with complicated DM—defined as having diabetic neuropathy, nephropathy, peripheral artery disease, and/or retinopathy—demonstrated a higher risk of delayed union or non-union compared with those with uncomplicated DM (OR = 1.80, 95% CI 1.42–2.28; I2 = 0%; Figure S4).Fig. 5Subgroup analysis based on diabetes type. Subgroup analysis based on diabetes type. Publication bias and sensitivity analysis A funnel plot was applied to evaluate the publication bias, indicating that there was no evidence of publication bias (Fig. 6A). In addition, the results of Begg’s test (p = 0.175) and Egger’s test (p = 0.396) also confirmed that there was no publication bias (Figure S5). To further explore the high heterogeneity observed in the overall analysis, we performed a sensitivity analysis. Sequential omission of each study did not materially change the pooled effect size, indicating that no single study disproportionately influenced the results (Fig. 6B).Fig. 6(A) Funnel plot of the included studies, (B) Sensitive analysis of the 36 included studies. (A) Funnel plot of the included studies, (B) Sensitive analysis of the 36 included studies. Discussion Diabetes is a prevalent comorbidity in patients with fractures, and our study was designed to evaluate the impact of diabetes on fracture healing. This systematic review and meta-analysis, which included 39 studies and 630,788 patients, demonstrates that diabetes is associated with a higher risk of delayed union or non-union following fractures. In addition, this direction of effect remained consistent across most subgroups and sensitivity analyses. These findings support the interpretation that diabetes represents an important clinical factor when evaluating fracture-healing risk. Regarding the impact of diabetes on fracture healing, the effect size observed in this meta-study was comparatively lower than that of the previous study (OR: 2.11, 95% CI 1.33–3.37; I2 = 56%) 13. This can be explained by the following reasons: (1) From August 2019 to November 2025, more than 20 articles investigating the correlation between diabetes and fracture healing were updated, many of which include patient populations benefiting from improved glycemic control, perioperative metabolic optimization, and advancements in diabetes management. These studies constituted two-thirds of the included studies and exerted a substantial influence on the outcomes of the meta-analysis. (2) In Zi-Chuan Ding’s study(August 2019), malunion, delayed union, and non-union were all included in the target outcome analysis and defined as impaired fracture healing13. We concur that malunion is mainly caused by malalignment and should be distinguished from compromised fracture healing capacity such as delayed union and non-union 16,17. Consequently, malunion was not included in the target outcome for this meta-analysis. (3). Other differences between the two meta-analyses—including variation in fracture patterns, clinical settings, population characteristics, and follow-up definitions—also likely influence the pooled effects. Therefore, the lower OR observed in our updated meta-analysis should be interpreted as the combined result of an expanded evidence base and temporal improvements in diabetes care, rather than the consequence of a single analytic decision. Subgroup analyses revealed consistent associations between diabetes and impaired healing across most anatomical sites. However, several subgroups—particularly proximal/distal fractures of the upper-extremity long bones and open fractures—were based on few studies and demonstrated wide confidence intervals, indicating limited precision. These findings should therefore be interpreted with caution, and additional adequately powered studies are needed to clarify whether anatomical location or fracture type modifies the effect of diabetes. Similarly, although both type 1 diabetes and complicated diabetes were associated with increased risk, the number of studies providing stratified data was small. The higher risk observed in type 1 diabetes and complicated diabetes is biologically plausible but remains exploratory. Further high-quality studies are warranted to validate this association. Non-union is the most serious outcome of impaired fracture healing. The US Federal Drug Administration defines non-unions as “failure to achieve union within 9 months of injury and no signs of healing for 3 months”18. Most of the studies we included were also based on this diagnostic criterion. However, some researchers hold the view that non-union can be diagnosed if there are no radiological signs of fracture healing after 6 months19. Orthopedic surgeons need to evaluate the risk of fracture non-union based on the patient’s situation and formulate an appropriate strategy to prevent the occurrence of non-union. In 2007, Giannoudis et al. introduced the “diamond concept” to illustrate the conditions required for good fracture healing, including three biological factors (osteoblasts, scaffolds, and growth factors) and one abiotic factor (mechanical stability)5,20. The impairment of any of the aforementioned four factors would compromise the process of fracture healing. The biological pathways through which diabetes impairs fracture healing are complex and remain incompletely understood. Numerous studies have suggested several mechanisms that may contribute to impaired fracture healing. (1) Diabetes can induce alterations in the immune microenvironment, including dysfunction of immune cells and upregulation of inflammatory factors, which impede the physiological activities of osteoclasts and osteoblasts21,22. (2) Diabetes can also induce the accumulation of reactive oxygen species (ROS), thereby leading to mitochondrial dysfunction, oxidative stress, and inhibition of osteoblast function through various signaling pathways, ultimately impacting fracture healing23. (3) Diabetes can induce microvascular remodeling and impede neovascularization, which exerts detrimental effects on the bone marrow microenvironment24. (4) In addition, the deficiency of osteogenic factors such as insulin and insulin-like growth factor, the increase of glycosylation end products, and hyperglycemia can also inhibit osteoblast function and impair bone healing25. Our findings highlight the need for clinicians to consider diabetes status when evaluating fracture healing risk. In this context, several authoritative guidelines provide clear recommendations for perioperative metabolic optimization in patients with diabetes sustaining fractures. The American College of Surgeons (ACS) perioperative guidelines identify diabetes as a modifiable surgical risk factor and recommend achieving glycemic optimization before definitive fracture fixation26,27. The American Diabetes Association (ADA) Standards of Care 2025 recommend maintaining perioperative blood glucose between 80 and 180 mg/dL to reduce risks of postoperative infection, delayed wound healing, and systemic complications28. Beyond metabolic control, our results also underscore several practical considerations relevant to surgical planning. Due to diabetes-related microvascular impairment, altered immune responses, and markedly increased susceptibility to wound complications, thorough preoperative soft-tissue assessment and meticulous intraoperative soft-tissue protection are essential. Furthermore, impaired bone metabolism and reduced bone quality in diabetic patients highlight the need for adequate mechanical stability. Many observational studies have reported higher rates of fixation failure in this population, suggesting that more rigid fixation constructs may be beneficial. Collectively, these data indicate that multidisciplinary co-management, strict glycemic control, aggressive infection prevention, and stable fixation represent the current evidence-based principles for caring for fracture patients with diabetes. This study is the most comprehensive meta-analysis up to now, which provides a better assessment of the impact of diabetes on fracture healing and has significant implications for guiding the treatment of diabetic fractures. Nevertheless, several limitations should be noted. First, most included studies reported unadjusted comparisons between diabetic and non-diabetic patients. As a result, residual confounding from age, obesity, smoking, comorbidities, or fracture severity cannot be excluded, and causality cannot be inferred. Second, diagnostic criteria for non-union varied across studies, which may have influenced outcome classification. Third, most of the studies were retrospective, limiting control over confounding and data quality. Fourth, subgroups examining diabetes type and diabetes complications were based on a small number of studies, limiting reliability. Finally, considerable heterogeneity was observed in the pooled analysis. This likely reflects methodological and clinical differences across studies, including variability in fracture patterns, diagnostic criteria for non-union, definitions of diabetes, unreported glycemic control, sample size, and differences in healthcare systems. Nevertheless, sensitivity analyses restricted to high-quality studies yielded an effect estimate nearly identical to the primary analysis, underscoring the robustness of the finding despite heterogeneity. Future prospective studies with standardized reporting may help identify clinical factors that modify the effect of diabetes on fracture healing. Conclusions This systematic review and meta-analysis found that diabetes is associated with an increased overall risk of delayed union or non-union following fractures. However, the strength and significance of this association varied across subgroups. These findings indicate that diabetes may contribute to impaired bone healing, but its impact is likely influenced by fracture characteristics, patient comorbidities, and study heterogeneity. Further high-quality prospective studies are needed to clarify these relationships, identify key effect modifiers, and inform evidence-based management strategies for fracture patients with diabetes. Supplementary Information Below is the link to the electronic supplementary material. Supplementary Material 1 Supplementary Material 1 Supplementary Material 2 Supplementary Material 2 Supplementary Material 3 Supplementary Material 3 Supplementary Material 4 Supplementary Material 4 Supplementary Material 5 Supplementary Material 5 Supplementary Material 6 Supplementary Material 6 Supplementary Material 7 Supplementary Material 7